SCHEMBL15085695

SCHEMBL15085695

COc1cc(Cl)c(C[C@@H](N)C(=O)O)c(Cl)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT5 Q9NXA8 1/20 0.41
▸ SLC7A5 Q01650 1/20 0.40
▸ MEN1 O00255 5/20 0.39
▸ KMT2A Q03164 5/20 0.39
▸ BLM P54132 2/20 0.39
▸ NR1I2 O75469 2/20 0.39
▸ PPARG P37231 2/20 0.39
▸ AGTR2 P50052 1/20 0.39
▸ USP2 O75604 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ THRB P10828 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NR1H4 Q96RI1 2/20 0.39
▸ PKM P14618 2/20 0.39
▸ RGS12 O14924 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23387528 0.89 ALDH1A1 (0.43) KMT2ALMNAALDH1A1PKMKDM4E
SCHEMBL15105447 0.89 ALDH1A1 (0.43) KMT2ALMNAALDH1A1PKMKDM4E
SCHEMBL30611535 0.89 ALDH1A1 (0.43) KMT2ALMNAALDH1A1PKMKDM4E
SCHEMBL27984878 0.86 GRM8 (0.41) MEN1KMT2ACYP2C9ALOX15ALDH1A1
SCHEMBL20837960 0.86 PTPN1 (0.42) SLC7A5MEN1KMT2ACYP2C9ALDH1A1
SCHEMBL15129207 0.86 PTPN1 (0.42) SLC7A5MEN1KMT2ACYP2C9ALDH1A1
SCHEMBL15105450 0.81 SMN1; SMN2 (0.37) LMNAALOX15ALDH1A1MAPTPKM
SCHEMBL15085689 0.79 MEN1 (0.48) SIRT5SLC7A5MEN1KMT2ABLM
SCHEMBL28075885 0.79 MEN1 (0.48) SIRT5SLC7A5MEN1KMT2ABLM
SCHEMBL31406980 0.79 ALDH1A1 (0.48) SLC7A5USP2HSD17B10ALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11931329-B2 Compositions and methods for treating anxiety-related disorders YAMO PHARMACEUTICALS LLC (US) 2024-03-19 — — US claimed
US-20240024268-A1 Methods for Dopamine Modulation in Human Neurologic Diseases SACKNER BERNSTEIN JONATHAN (US) 2024-01-25 — — US claimed
US-20240016815-A1 COMPOSITIONS AND METHODS FOR MODULATING CANCER IN NON-HUMAN MAMMALS HOFFMAN TECHNOLOGIES LLC 2024-01-18 — — US claimed
US-11806326-B2 Methods for dopamine modulation in human neurologic diseases SACKNER BERNSTEIN JONATHAN (US) 2023-11-07 — — US claimed
US-11786496-B2 Composition and methods for treating intestinal hyperpermeability YAMO PHARMACEUTICALS LLC (US) 2023-10-17 — — US claimed
US-20230141609-A1 Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms YAMO PHARMACEUTICALS LLC (US) 2023-05-11 — — US claimed
US-20230040681-A1 COMPOSITIONS AND METHODS FOR TREATING ANXIETY-RELATED DISORDERS YAMO PHARMACEUTICALS LLC (US) 2023-02-09 — — US claimed
US-11534420-B2 Compositions and methods for treating cancer TYME, INC. (US) 2022-12-27 — — US claimed
CN-115515575-A Tyrosine derivatives for the modulation of cancer 迪美公司 2022-12-23 — — CN claimed
CN-114901272-A Sustained release preparation 霍夫曼技术有限责任公司 2022-08-12 — — CN claimed
WO-2015061256-A1 HIGH-SPEED CENTRIFUGAL MIXING DEVICES AND METHODS OF USE TYME, INC. (US) 2015-04-30 — — WO claimed
WO-2015061288-A1 TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM TYME, INC. (US) 2015-04-30 — — WO claimed
US-20150110735-A1 HIGH-SPEED CENTRIFUGAL MIXING DEVICES AND METHODS OF USE OXFORD FINANCE LLC, AS COLLATERAL AGENT 2015-04-23 — — US claimed
US-20150112116-A1 TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM OXFORD FINANCE LLC, AS COLLATERAL AGENT 2015-04-23 — — US claimed
US-20150111937-A1 Compositions and Methods for Treating Intestinal Hyperpermeability YAMO PHARMACEUTICALS LLC 2015-04-23 — — US claimed
US-20150111878-A1 COMPOSITIONS AND METHODS FOR TREATING INTESTINAL HYPERPERMEABILITY HOFFMAN STEVEN (US) 2015-04-23 — — US claimed
EP-2804599-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS Tyme, Inc. (US) 2014-11-26 — — EP claimed
WO-2013109610-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS HOFFMAN STEVEN (US) 2013-07-25 — — WO claimed
US-20130184214-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OXFORD FINANCE LLC, AS COLLATERAL AGENT 2013-07-18 — — US claimed
US-8481498-B1 Pharmaceutical compositions and methods OXFORD FINANCE LLC, AS COLLATERAL AGENT 2013-07-09 — — US claimed
Send feedback